Appearance | white to beige powder |
Purity / Analysis Method | ≥98% (HPLC) |
storage temperature | −20°C |
Darunavir
[(1R,5S,6R)-2,8-dioxabicyclo[3.3.0]oct-6-yl] N-[(2S,3R)-4- [(4-aminophenyl)sulfonyl- (2-methylpropyl)amino]-3-hydroxy-1-phenyl- butan-2-yl]
Purity / Analysis Method | ≥98% (HPLC) |
Molecular Formula / Molecular Weight | C27H37N3O7S = 547.66 |
Form | Powder |
CAS RN | 206361-99-1 |
Unit | Price |
10 mg | 14500 |
50 mg | POR |
100 mg | POR |
Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
---|